
Medincell SA
PAR:MEDCL

Intrinsic Value
The intrinsic value of one
MEDCL
stock under the Base Case scenario is
21.85
EUR.
Compared to the current market price of 13.62 EUR,
Medincell SA
is
Undervalued by 38%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Medincell SA
Fundamental Analysis


Revenue & Expenses Breakdown
Medincell SA
Balance Sheet Decomposition
Medincell SA
Current Assets | 47.8m |
Cash & Short-Term Investments | 38.9m |
Receivables | 7.1m |
Other Current Assets | 1.8m |
Non-Current Assets | 11.1m |
Long-Term Investments | 3.3m |
PP&E | 5.2m |
Intangibles | 2.6m |
Other Non-Current Assets | -1k |
Free Cash Flow Analysis
Medincell SA
EUR | |
Free Cash Flow | EUR |
Earnings Waterfall
Medincell SA
Revenue
|
10.7m
EUR
|
Cost of Revenue
|
-896k
EUR
|
Gross Profit
|
9.8m
EUR
|
Operating Expenses
|
-29.3m
EUR
|
Operating Income
|
-19.5m
EUR
|
Other Expenses
|
-11.9m
EUR
|
Net Income
|
-31.4m
EUR
|
MEDCL Profitability Score
Profitability Due Diligence
Medincell SA's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Score
Medincell SA's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
MEDCL Solvency Score
Solvency Due Diligence
Medincell SA's solvency score is 33/100. The higher the solvency score, the more solvent the company is.

Score
Medincell SA's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
MEDCL Price Targets Summary
Medincell SA
According to Wall Street analysts, the average 1-year price target for
MEDCL
is 22.25 EUR
with a low forecast of 18.48 EUR and a high forecast of 26.25 EUR.
Dividends
Current shareholder yield for MEDCL is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
MEDCL
stock under the Base Case scenario is
21.85
EUR.
Compared to the current market price of 13.62 EUR,
Medincell SA
is
Undervalued by 38%.